The B cell—old player, new position on the team
HF McFarland - New England Journal of Medicine, 2008 - Mass Medical Soc
HF McFarland
New England Journal of Medicine, 2008•Mass Medical SocThe benefits of therapies targeting B cells in autoimmune diseases have led to increased
interest in the role of B cells in diseases that have been thought to be largely mediated by T
cells. Dr. Henry McFarland discusses the B-cell–mediated processes that may explain the
effect of rituximab on disease activity in multiple sclerosis.
interest in the role of B cells in diseases that have been thought to be largely mediated by T
cells. Dr. Henry McFarland discusses the B-cell–mediated processes that may explain the
effect of rituximab on disease activity in multiple sclerosis.
The benefits of therapies targeting B cells in autoimmune diseases have led to increased interest in the role of B cells in diseases that have been thought to be largely mediated by T cells. Dr. Henry McFarland discusses the B-cell–mediated processes that may explain the effect of rituximab on disease activity in multiple sclerosis.
The New England Journal Of Medicine